Effects of tyrosinase activity on the cytotoxicity of 3,4-dihydroxybenzylamine and buthionine sulfoximine in human melanoma cells.
Effects of tyrosinase activity on the cytotoxicity of 3,4-dihydroxybenzylamine and buthionine sulfoximine in human melanoma cells.
复制标题
酪氨酸酶活性对人黑色素瘤细胞中 3,4-二羟基苄胺和丁硫氨酸亚磺酰亚胺细胞毒性的影响。
DOI:
10.1111/j.1600-0749.1990.tb00322.x
复制
发表时间:
1990
期刊:
影响因子:
--
通讯作者:
Wick,MM
中科院分区:
文献类型:
--
作者:
Prezioso,JA;Fitzgerald,GB;Wick,MM
The rationale for melanoma specific dihydroxybenzene containing antitumor agents is based in part upon the ability of the enzyme tyrosinase to oxidize these pro drugs to toxic intermediates. In situ tyrosinase activity was demonstrated to be affected by both cell density and time from plating in pigmented melanoma cells. Phenylthiourea, which completely inhibited tyrosinase activity with minimal cytotoxicity was found to block the growth inhibitory activity of the antitumor dopamine analog 3,4‐dihydroxybenzylamine (3,4‐DHBA) (NSC 263475). The antioxidant dithioerythritol was also found to inhibit tyrosinase activity and to block the growth inhibitory effects of 3,4‐DHBA in pigmented melanoma cell lines. Buthionine sulfoximine (BSO) was shown to be cytotoxic to melanoma cells and its growth inhibitory effects appears to correlate with tyrosinase levels. Furthermore, BSO was shown to potentiate the growth inhibitory effects of 3,4‐DHBA on marginally pigmented human melanoma cell lines.